Taysha Gene Therapies Inc (TSHA)

SG&A Expenses

$12.15M

Quarterly · Period ending: · USD

TSHA logo

TSHA SG&A Expenses

Latest reported$12.15M
TSHA Quarterly SG&A Expenses ($128.00K → $12.15M)
High-resolution chart · PNG

TSHA sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Taysha Gene Therapies Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
12,146,000
9,677,000
8,833,000
8,279,000
8,598,000
8,158,000
6,629,000
7,902,000
7,338,000
7,084,000
6,719,000
8,257,999
5,285,000
8,119,999
5,662,000
8,683,000
9,867,000
11,469,000
11,806,000
11,153,000
10,129,000
8,236,000
6,107,000
3,984,000
948,000
70,000
128,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.